As expected, the expression levels of SPP1, IL6R, CD68, and AGT were found to be up-regulated while FNDC5 and RETN levels were down-regulated in PPAT samples from patients with PCa vs. BPH after data normalization. This evidence concerns the gene SPP1 and benign prostatic hyperplasia.